Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
21.06
+0.31 (1.49%)
At close: Nov 4, 2026, 4:00 PM EST
21.99
+0.93 (4.42%)
After-hours: Nov 4, 2026, 7:58 PM EST
Takeda Pharmaceutical Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 418,533 | 595,054 | 385,113 | 457,800 | 533,530 | 849,695 |
Cash & Short-Term Investments | 418,533 | 595,054 | 385,113 | 457,800 | 533,530 | 849,695 |
Cash Growth | -38.59% | 54.51% | -15.88% | -14.19% | -37.21% | -12.06% |
Accounts Receivable | 872,682 | 808,025 | 651,415 | 612,439 | 575,431 | 617,517 |
Other Receivables | 37,563 | 68,323 | 73,839 | 85,171 | 106,262 | 106,860 |
Receivables | 910,245 | 876,348 | 725,254 | 697,610 | 681,693 | 724,377 |
Inventory | 1,441,087 | 1,396,620 | 1,217,349 | 1,209,869 | 986,457 | 853,167 |
Other Current Assets | 227,291 | 222,481 | 193,476 | 193,301 | 196,276 | 166,403 |
Total Current Assets | 2,997,156 | 3,090,503 | 2,521,192 | 2,558,580 | 2,397,956 | 2,593,642 |
Property, Plant & Equipment | 2,281,914 | 2,120,639 | 1,968,209 | 1,989,777 | 1,691,229 | 1,582,800 |
Long-Term Investments | 8,617 | 8,796 | 10,802 | 89,831 | 99,174 | 96,579 |
Goodwill | 5,684,518 | 5,809,010 | 5,324,430 | 5,410,067 | 4,790,723 | 4,407,749 |
Other Intangible Assets | 3,218,033 | 3,419,348 | 3,631,560 | 4,274,682 | 4,269,657 | 3,818,544 |
Long-Term Deferred Tax Assets | 607,522 | 546,260 | 370,745 | 393,865 | 366,003 | 362,539 |
Other Long-Term Assets | 473,738 | 516,950 | 421,406 | 391,990 | 343,008 | 316,165 |
Total Assets | 15,271,498 | 15,511,506 | 14,248,344 | 15,108,792 | 13,957,750 | 13,178,018 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 486,196 | 324,368 | 308,450 | 319,955 | 307,453 | 295,934 |
Short-Term Debt | - | 26 | 344,621 | 317,251 | 40,256 | 285 |
Current Portion of Long-Term Debt | 400,974 | 512,131 | 204,318 | 50,000 | 299,344 | 203,708 |
Current Portion of Leases | - | 65,443 | 64,443 | 66,208 | 59,623 | 53,877 |
Current Income Taxes Payable | 117,080 | 97,880 | 133,497 | 109,906 | 232,377 | 200,918 |
Other Current Liabilities | 1,599,299 | 1,832,226 | 1,451,192 | 1,449,783 | 1,542,887 | 1,391,008 |
Total Current Liabilities | 2,603,549 | 2,832,074 | 2,506,521 | 2,313,103 | 2,481,940 | 2,145,730 |
Long-Term Debt | 4,174,676 | 4,369,681 | 3,966,326 | 4,476,501 | 4,042,741 | 4,141,418 |
Long-Term Leases | 781,767 | 529,077 | 508,882 | 553,431 | 419,728 | 411,361 |
Pension & Post-Retirement Benefits | 132,188 | 143,683 | 135,429 | 143,882 | 127,594 | 145,847 |
Long-Term Deferred Tax Liabilities | 24,287 | 26,804 | 35,153 | 113,777 | 270,620 | 451,511 |
Other Long-Term Liabilities | 137,855 | 179,538 | 160,054 | 234,093 | 260,456 | 198,628 |
Total Liabilities | 7,854,322 | 8,080,857 | 7,312,365 | 7,834,787 | 7,603,079 | 7,494,495 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 1,722,947 | 1,695,277 | 1,694,685 | 1,676,596 | 1,676,345 | 1,676,263 |
Additional Paid-In Capital | 1,758,304 | 1,776,352 | 1,775,713 | 1,747,414 | 1,728,830 | 1,708,873 |
Retained Earnings | 859,247 | 712,381 | 1,187,586 | 1,391,203 | 1,541,146 | 1,479,716 |
Treasury Stock | -20,913 | -49,128 | -74,815 | -51,259 | -100,317 | -116,007 |
Comprehensive Income & Other | 3,096,600 | 3,294,559 | 2,351,915 | 2,509,310 | 1,508,118 | 934,174 |
Total Common Equity | 7,416,185 | 7,429,441 | 6,935,084 | 7,273,264 | 6,354,122 | 5,683,019 |
Minority Interest | 991 | 1,208 | 895 | 741 | 549 | 504 |
Shareholders' Equity | 7,417,176 | 7,430,649 | 6,935,979 | 7,274,005 | 6,354,671 | 5,683,523 |
Total Liabilities & Equity | 15,271,498 | 15,511,506 | 14,248,344 | 15,108,792 | 13,957,750 | 13,178,018 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 5,357,417 | 5,476,358 | 5,088,590 | 5,463,391 | 4,861,692 | 4,810,649 |
Net Cash (Debt) | -4,938,884 | -4,881,304 | -4,703,477 | -5,005,591 | -4,328,162 | -3,960,954 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -3119.25 | -3099.12 | -2929.93 | -3167.41 | -2757.02 | -2511.43 |
Filing Date Shares Outstanding | 1,597 | 1,580 | 1,574 | 1,569 | 1,555 | 1,550 |
Total Common Shares Outstanding | 1,597 | 1,580 | 1,574 | 1,569 | 1,555 | 1,550 |
Working Capital | 393,607 | 258,429 | 14,671 | 245,477 | -83,984 | 447,912 |
Book Value Per Share | 4642.52 | 4702.66 | 4407.01 | 4635.57 | 4087.49 | 3665.61 |
Tangible Book Value | -1,486,366 | -1,798,917 | -2,020,906 | -2,411,485 | -2,706,258 | -2,543,274 |
Tangible Book Value Per Share | -930.46 | -1138.67 | -1284.22 | -1536.94 | -1740.89 | -1640.44 |
Land | - | 108,774 | 104,342 | 105,845 | 98,227 | 98,654 |
Buildings | - | 1,064,895 | 955,045 | 937,156 | 826,523 | 763,460 |
Machinery | - | 1,287,166 | 1,151,992 | 1,124,798 | 976,111 | 893,628 |
Construction In Progress | - | 394,889 | 321,656 | 278,689 | 207,400 | 154,960 |